E.C. de Heer
Telephone:
E-mail:
e.c.de.heer umcg.nl
Research
- 2020
- Dutch Upper Gastrointestinal Cancer Audit (DUCA) Group, Wang, H. H., de Heer, E. C., Hulshoff, J. B., Kats-Ugurlu, G., Burgerhof, J. G. M., van Etten, B., Plukker, J. T. M., & Hospers, G. A. P. (2020). Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-020-09372-y
- de Heer, E. C., Jalving, M., & Harris, A. L. (2020). HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. The Journal of Clinical Investigation, 130(10), 5074-5087. https://doi.org/10.1172/JCI137552
- van Sluis, J., de Heer, E. C., Boellaard, M., Jalving, M., Brouwers, A. H., & Boellaard, R. (2020). Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-020-05068-3
- 2018
- de Heer, E. C., Brouwers, A. H., Boellaard, R., Sluiter, W. J., Diercks, G. F. H., Hospers, G. A. P., de Vries, E. G. E., & Jalving, M. (2018). Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-18-FDG PET/CT analysis. EJNMMI Research, 8(1), [101]. https://doi.org/10.1186/s13550-018-0453-x
- 2017
- de Heer, E. C., Hulshoff, J. B., de Klerk, M., Burgerhof, J. G. M., de Groot, D. J. A., Plukker, J. T. M., & Hospers, G. A. P. (2017). Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer. Annals of Surgical Oncology, 24(7), 1811-1820. https://doi.org/10.1245/s10434-017-5797-3
ID: 66834987